ESMO - The Christie Preceptorship on Lung Cancer 2023: Manchester
- Start date
- 01 Mar 2023
- End date
- 03 Mar 2023
- Location
- Manchester, United Kingdom
Learning objectives
- To learn about the evidence-base for lung cancer screening and novel diagnostic modalities
- To learn about the management of early stage NSCLC and use of adjuvant treatments
- To understand the role of multi-modality treatment in locally advanced NSCLC and limited stage SCLC
- To learn about the management of patients with actionable driver mutations and novel targeted agents for advanced NSCLC
- To understand the role of immune-checkpoint blockade for lung cancer and to learn about novel immunotherapies
- To learn about treatment of NSCLC with oligometastatic disease
- To learn about the systemic treatment of mesothelioma and SCLC
- To learn about the role of supportive and palliative care for thoracic malignancies
Accreditation
The programme of this event has been accredited with 16 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
Fiona Blackhall, United Kingdom
Raffaele Califano, United Kingdom
Pilar Garrido Lopez, Spain
Supported by
